Draft:Anita Gupta
 | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by Qwerfjkl (bot) (talk | contribs) 29 days ago. (Update) |
Anita Gupta | |
|---|---|
| Nationality | American |
| Education | Philadelphia College of Osteopathic Medicine (D.O.), University of Oxford (M.P.P.), Princeton University, Harvard Business School |
| Occupation(s) | Anesthesiologist, pharmacologist, healthcare policy expert |
| Employer(s) | Johns Hopkins University, DOCS Health |
| Known for | Work on opioid crisis, COVID-19 public health communication |
Anita Gupta is an American anesthesiologist, pharmacologist, and healthcare policy expert. She is a faculty member at the Johns Hopkins School of Medicine and serves as Chief Surgeon for DOCS Health's management division.[1] Gupta is widely recognized for her contributions to opioid policy, pain medicine, and public education during the COVID-19 pandemic.
Early Life and Education
[edit]Gupta grew up in Philadelphia, where she was raised by a mother who worked in education and a father who practiced veterinary medicine. She began her undergraduate studies at The College of New Jersey before transferring to the Ernest Mario School of Pharmacy. There, she earned both a Bachelor of Science and a Doctor of Pharmacy (Pharm.D.) degree. She later joined Organon & Co., which eventually became part of Merck & Co., Inc., gaining early industry experience before pursuing a medical degree.
Gupta completed her medical training at Rowan University School of Osteopathic Medicine, earning her D.O. degree. She then underwent a residency in anesthesiology at the Georgetown University School of Medicine and completed a fellowship in interventional pain management at the Johns Hopkins School of Medicine.[2]
In 2018, she earned a Master in Public Policy from Princeton University with a focus on health and healthcare policy.[3] Two years later, she completed the General Management Program at Harvard Business School, where she served as class speaker and was named a program ambassador.[4]
Career
[edit]Gupta is a faculty member at Johns Hopkins University and previously served in clinical and advisory roles at Drexel University and Temple University.[5] She has been a leading voice on issues related to pain management, opioid misuse, and drug policy. Gupta has advised federal agencies, including the Food and Drug Administration, on expanding access to naloxone and combatting the synthetic opioid crisis.[6][7]
During the COVID-19 pandemic, Gupta was frequently cited as an expert on pain medicine and public health. She appeared in major media outlets such as The New York Times, USA Today, and WebMD, advising against the preemptive use of ibuprofen before COVID-19 vaccination and discussing long-term immunity and public safety protocols.[8][9][10]
She also contributed to public understanding of monoclonal antibody treatments and the flu-COVID coinfection risk.[11][12]
Gupta is a frequent contributor to healthcare policy discussions, writing for platforms such as Forbes and FierceHealthcare on topics including sustainability in healthcare, digital health transformation, and data analytics.[13][14] She has published extensively in academic journals and contributed to books on anesthesia pharmacology.[15][16]
Honors and recognition
[edit]Gupta has been recognized as one of the “Top Women of Influence” by FierceHealthcare[17] and was named one of the “Emerging Pharma Leaders” by Pharmaceutical Executive.[18] She has also been featured in the PharmaVoice 100 list.[19] In 2022 she received the Patient Advocacy Award from the National Academies of Practices.
Gupta is affiliated with global health and policy organizations including the Milken Institute and the World Economic Forum.[20][21]
Selected works
[edit]- Gupta, A. (2013). "Pharmacology in Anesthesia Practice." European Journal of Anaesthesiology.
- Contributor, Pharmacology in Anesthesia Practice, Oxford Academic, 2021.
References
[edit]- ^ "Dr. Anita Gupta Appointed As New Chief Surgeon Of DOCS Health Management Division". Norwood News. October 18, 2022.
- ^ Ravindranath, Mohana (2020-12-07). "Maintaining telehealth's momentum". Politico. Retrieved 2022-02-26.
- ^ Daugherty, Elisabeth H. (2020-09-02). "Sept. 1: Jeff Bezos '86 breaks $200 billion; Anita Gupta *18 manages COVID pain". Princeton Alumni Weekly. The Trustees of Princeton University. Retrieved 2022-02-23.
- ^ "Transformation in the Classroom and the Frontlines". Executive Education. Harvard Business School. Retrieved 2022-02-23.
- ^ "Anita Gupta, D.O., Pharm.D., M.P.P." Johns Hopkins Medicine.
- ^ "ASA Urges FDA to Expand Access to Naloxone". American Society of Anesthesiologists. July 2015.
- ^ "Anesthesiologist Links Antidote Resistance to Killer Synthetic Opioid W-18". Newswise.
- ^ Rabin, Roni Caryn (January 19, 2022). "Do You Need Another Covid Booster?". The New York Times.
- ^ "Taking common pain relievers before COVID-19 vaccination could lessen efficacy, experts say". FOX 32 Chicago.
- ^ "VERIFY: Avoid ibuprofen before COVID-19 vaccine, OK afterward". 9News.
- ^ "Can You Get the Flu and COVID-19 at the Same Time?". Health.
- ^ "AstraZeneca's Monoclonal Antibody for COVID-19: What to Know". Prevention.
- ^ "Sustainability, Data Analytics and More: 3 Trends in the Future of Healthcare". Becker's Hospital Review.
- ^ "The Future Of Health: Three Healthcare Trends For 2022". Forbes.
- ^ "Pharmacology in Anesthesia Practice". European Journal of Anaesthesiology. 30 (10): 570–572. 2013. doi:10.1097/EJA.0b013e328362b8ba.
- ^ "Book Contributor: Pharmacology in Anesthesia Practice". Oxford Academic.
- ^ "FierceHealthcare's 2021 Women of Influence Awards". FierceHealthcare.
- ^ "Pharmaceutical Executive Announces Winners of the 2020 Emerging Pharma Leaders Awards". Bloomberg (Press release).
- ^ "PharmaVoice 100 – Anita Gupta". PharmaVoice.
- ^ "Speaker Profile: Anita Gupta". Milken Institute.
- ^ "Anita Gupta". World Economic Forum.